Kairos Ventures

Type

Venture Capital

Status

Active

Location

Beverly Hills, United States

Total investments

57

Average round size

7M

Portfolio companies

44

Rounds per year

7.12

Lead investments

4

Follow on index

0.23

Exits

1

Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsChemical

Summary

Kairos Ventures is the famous VC, which was founded in 2015. The leading representative office of defined VC is situated in the Beverly Hills. The company was established in North America in United States.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Kairos Ventures, startups are often financed by Tech Coast Angels, Foundation Venture Capital Group, The Angels' Forum. The meaningful sponsors for the fund in investment in the same round are Spruce Capital Partners, Penn Medicine Co-Investment Fund, DEFTA Partners. In the next rounds fund is usually obtained by Spruce Capital Partners, BASF Venture Capital, Vesalius Biocapital Partners.

This organization was formed by James Demetriades. The overall number of key employees were 3.

Speaking about the real fund results, this VC is 25 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. This Kairos Ventures works on 26 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2015. The fund is generally included in 7-12 deals every year.

Among the most popular portfolio startups of the fund, we may highlight Axial Biotherapeutics, Provivi, Neuro-Bio. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Renewable Energy, Health Care.

Show more

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
Seed
Geo focus
Generalist
Check size
150K — 20M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 58000000
Fund raised date
2022-01-13

Analytics

Total investments
57
Lead investments
4
Exits
1
Rounds per year
7.12
Follow on index
0.23
Investments by industry
  • Biotechnology (27)
  • Health Care (18)
  • Medical (13)
  • Therapeutics (12)
  • Pharmaceutical (10)
  • Show 64 more
Investments by region
  • United States (55)
  • United Kingdom (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.37
Avg. company exit year
5

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
3D Bio Holdings 28 Jun 2017 Biotechnology, Health Care, Pharmaceutical Seed United States, New York, New York
Enotek 04 Jan 2022 Early Stage Venture 15M Shanghai, Minhang, China
Vivodyne 11 Mar 2021 Biotechnology, Medical, Lifestyle Seed 2M United States, Pennsylvania, Philadelphia
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.